AstraZeneca acquires CSPC Pharmaceutical Group

AstraZeneca agreed to acquire CSPC Pharmaceutical Group. Reported deal value: $5B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-02-02. Figures and status may change as filings and press coverage update.

AstraZeneca signs up to US$18.5 billion obesity drug deal with China CSPC Posted by Global Cosmetics News | Feb 2, 2026 | Asia & Australasia, Europe, Finance, Manufacturing , Wellness | THE WHAT? AstraZeneca has agreed a major obesity -focused licensing deal with China CSPC Pharmaceutical Group , worth up to US$18.5 billion , as it accelerates its push into the fast-growing weight - loss market